332 related articles for article (PubMed ID: 10807052)
1. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation.
Kline RM; Stiehm ER; Cowan MJ
Bone Marrow Transplant; 1996 Apr; 17(4):543-8. PubMed ID: 8722352
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
[TBL] [Abstract][Full Text] [Related]
6. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
7. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).
Dickinson AM; Reid MM; Abinun M; Peak J; Brigham K; Dunn J; Cant AJ
Bone Marrow Transplant; 1997 Feb; 19(4):323-9. PubMed ID: 9051241
[TBL] [Abstract][Full Text] [Related]
8. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
10. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
[TBL] [Abstract][Full Text] [Related]
12. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.
Martín-Hernández MP; Arrieta R; Martínez A; García P; Jimenez-Yuste V; Hernandez-Navarro F
Bone Marrow Transplant; 1997 Nov; 20(9):797-9. PubMed ID: 9384486
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
15. Matched unrelated bone marrow transplantation for combined immunodeficiency.
Dalal I; Reid B; Doyle J; Freedman M; Calderwood S; Saunders F; Roifman CM
Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
17. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies.
Slatter MA; Bhattacharya A; Flood TJ; Spickett GP; Cant AJ; Abinun M; Gennery AR
Bone Marrow Transplant; 2003 Jul; 32(2):225-9. PubMed ID: 12838289
[TBL] [Abstract][Full Text] [Related]
19. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
Meijer E; Slaper-Cortenbach IC; Thijsen SF; Dekker AW; Verdonck LF
Bone Marrow Transplant; 2002 Feb; 29(4):335-9. PubMed ID: 11896431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
